Inventor · disambiguated record
Joachim Almquist
Also filed as: ALMQUIST JOACHIM
1 granted patent·6 pending applications·2 citations·filing 2022–2024
24Inventor score
Files withASTRAZENECA AB7
Top patents by PatentIndex Score
7 records- 0186US12060429B2Method of treating type 1 interferon (IFN)-mediated disease using a subcutaneous dosing regimen comprising anifrolumabASTRAZENECA AB·Filed 2023·Granted Aug 13, 2024·2 cites·10 claims
- 0273US2024400699A1Anti-ifnar1 dosing regime for subcutaneous injectionASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0372US2024360231A1DoseASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0465US2022340669A1DoseASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0561US2025002590A1Treatment of lupus nephritis with anti-type i inf receptor antibody anifrolumabASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0661US2022348669A1Treatment of lupus nephritisASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0757US2025002589A1Treatment of cutaneous lupus erythematousASTRAZENECA AB·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joachim Almquist files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →